Do the Math: Ram Selvaraju on the Appeal of Biotechs in Orphan Diseases

The Life Sciences Report | |

To cast a spotlight on disruptive biotechnology stocks, Raghuram "Ram" Selvaraju of Aegis Capital Corp. taps his experience as a molecular biologist, preclinical investigator and

How Did High Flyers Turn into Soul Searchers? Maxim Analyst Jason Kolbert on the Highs and Lows of Biotech Valuations

The Life Sciences Report | |

After soaring more than 56% last year, the NASDAQ Biotechnology Index is down almost 15% in March. In this interview with The Life Sciences Report, Jason Kolbert of the Maxim Group points to

Medivation Plunges on Low Sales Guidance for Xtandi

Joel Anderson | |

Small-cap biotechnology firm Medivation (MDVN) saw shares plummet almost 14.5 percent on Feb 28 after a Q4 2013 earnings report featured softer guidance for sales of its lead therapy, Xtandi,

Biotech, Health Care ETFs Fall for Third Straight Day

Joel Anderson | |

Biotech stocks continued a rough week on Wednesday, with the iShares Nasdaq Biotechnology Fund ($IBB) down more than 2.5 percent in early trading, and off by almost 9 percent since Monday. This

Aegis Capital Is Changing the Way Investors Look at HealthCare Stocks

Equities Editors Desk | |

For the entire furor surrounding the upcoming implementation of “Obamacare” at the start of next year, few have been able to advance anything that resembles a comprehensive assessment

Equities Sector Coverage: Stocks Resume Downward Trend

Sector Recap | |

The Dow Jones Industrial Average traded down to 12,661.48 Monday morning then rebounded above 12,760 in the afternoon before fading in the final hour of trading. The NASDAQ traded down to 2898.90

Equities Sector Coverage: Investor Optimism Returns to Wall Street

Sector Recap | |

Initial Jobless Claims for the week ending March 3 was 362,000, an increase of 8,000 from the previous week's revised figure of 354,000. The Dow Jones Industrial Average rallied to an afternoon

Equities Sector Coverage: Wall Street Pushes Higher

Sector Recap | |

The ISM Manufacturing Index rose to 54.1 in January from 53.1 in December. Construction Spending rose by 1.5% in December. The Dow Jones Industrial Average traded higher at the open to 12,784.62

Highlights in Health Care 2011

Brittney Barrett | |

Healthcare is traditionally considered a defensive sector and in 2011 it lived up to its name. Investors flocked toward it, driving it higher by 13.2 percent for the year as new regarding

Equities Sector Coverage: Wall Street Stays Positive Despite Volatility

Sector Recap | |

Initial Jobless Claims came out at 390,000 in the latest week still above the 350,000 recessionary threshold. The Trade Deficit came in at $43.11 billion in September. Import Prices were down 0.6%

Sponsored Financial Content

Market Movers